You are here


WSN granted for its ImmunoSarc project


The Liddy Shriver Sarcoma Initiative awarded a $340,400 research grant for WSN (collaborative study) on the immune system and the potential role of immunotherapy in sarcomas. The grant brings together investigators from Austalia, Canada, France and the United States in a two-year study of two sarcoma subtypes.

Using medicine to help a patient's immune system fight cancer is an exciting area of research today. Despite the fact that cancer immunotherapy was named Science magazine’s 2013 advance of the year, few immunotherapy options exist for people with sarcomas. This study aims to reveal the immune system's role in osteosarcoma and undifferentiated pleomorphic sarcoma and to build a foundation for the use of immunotherapy in sarcoma treatment.

Know more about the study. 

Know more about WSN